# Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

> **NCT06892093** · NA · RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 308 (estimated)

## Conditions studied

- HER2-positive Breast Cancer
- Diarrhea Caused by Drug
- Neratinib

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotics
- **DIETARY_SUPPLEMENT:** Placebo
- **DRUG:** Loperamide

## Key facts

- **NCT ID:** NCT06892093
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-07
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 308 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06892093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06892093, "Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06892093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*